-
August 28, 2012
Nordion arbitration decision expected Sept. 10
Ottawa-based medical isotope maker Nordion Inc. (TSX: NDN; NYSE: NDZ) says it expects an “important” ruling in less than two weeks that could end a four-year dispute…
Read More -
August 17, 2011
Certain Injectable and Inhalational Sterile Drugs Imported from Ben Venue Laboratories Inc. – Potential Supply Shortage – Notice to Hospitals
Health Canada is advising Healthcare Professionals of a…
Read More -
January 20, 2011
AECL reports on NRU operating progress at CNSC Commission Hearing
Reactor Performance Meets Expectations as AECL Provides Six Month Update to Commission. Atomic Energy of Canada Limited (AECL) today appeared…
Read More -
July 9, 2009
Maintenance Stop High Flux Reactor Petten
The annual summer stop of the High Flux Reactor in Petten, during which regular preventative maintenance, testing and inspection is performed is planned for the period…
Read More -
March 10, 2009
Production of 99Mo for Nuclear Medicine by 100Mo(n,2n)99Mo
We have proposed a new route to produce 99Mo for nuclear medicine by the 100Mo(n,2n)99Mo reaction. The reaction cross section is known to be ∼1.5 b in the neutron energy, En, range…
Read More -
February 25, 2009
B&W taps DOE official to head isotope program
Babcock & Wilcox has picked Daniel E. Glenn, a Department of Energy official, to lead research and development for its medical-isotope initiative, which might lead to the establishment…
Read More